Brief: Vincerx Pharma, Inc. Q2 Basic EPS USD -0.52
07/08/2023 14:26
Aug 7 (Reuters) - Vincerx Pharma, Inc. Q2 basic EPS USD -0.52. * Q2 net income USD -11.151 million * Q2 income from operations USD -11.66 million * Q2 operating expenses USD 11.66 million
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign